AVANOS MEDICAL INC (AVNS)

US05350V1061 - Common Stock

18.71  -0.05 (-0.27%)

After market: 18.6819 -0.03 (-0.15%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
744.6M
4.17%		820M
10.13%		673.3M
-17.89%		704.82M
4.68%
EBITDA
YoY % growth
55M
1,818.75%		123.7M
124.91%		50.3M
-59.34%		118.88M
136.34%
EBIT
YoY % growth
16.7M
136.23%		76M
355.09%		4.2M
-94.47%		106.74M
2,441.43%
Operating Margin
2.24%9.27%0.62%15.14%
EPS
YoY % growth
1.15
47.44%		1.65
43.48%		1.38
-16.36%		1.40
1.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.22
-18.90%
Revenue
Q2Q % growth		166.16M
4.31%
EBITDA
Q2Q % growth		20.757M
EBIT
Q2Q % growth		16.677M
462.54%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.32
-46.67%		0.37-0.05-14.44%
Q3 2023
Q2Q % growth		 0.42
10.53%		0.290.1347.06%
Q2 2023
Q2Q % growth		 0.37
-9.76%		0.300.0721.73%
Q1 2023
Q2Q % growth		 0.27
3.85%		0.28-0.01-3.48%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 173.3M
-20.32%		173.84M-540K-0.31%
Q3 2023
Q2Q % growth		 171.3M
-0.58%		172.99M-1.69M-0.98%
Q2 2023
Q2Q % growth		 169.4M
-0.88%		189.95M-20.55M-10.82%
Q1 2023
Q2Q % growth		 159.3M 199.1M-39.8M-19.99%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -19.2% 0% -9.21%
Revenue0% -1.98% 0% -3.28%